Scarica l'app Stockscreener
20.82
2.21%
-0.47
Dopo l'orario di chiusura:
20.82
Precedente Chiudi:
$21.29
Aprire:
$21.27
Volume 24 ore:
546.59K
Relative Volume:
1.17
Capitalizzazione di mercato:
$1.23B
Reddito:
-
Utile/perdita netta:
$-85.21M
Rapporto P/E:
-11.02
EPS:
-1.89
Flusso di cassa netto:
$-68.53M
1 W Prestazione:
+6.17%
1M Prestazione:
+8.32%
6M Prestazione:
+39.64%
1 anno Prestazione:
-22.80%
Intervallo 1D:
$20.59
$21.31
Intervallo di 1 settimana:
$19.48
$21.81
Portata 52W:
$13.30
$30.03
Enliven Therapeutics Inc Stock (ELVN) Company Profile
Nome
Enliven Therapeutics Inc
Settore
Industria
Telefono
720-647-8519
Indirizzo
6200 LOOKOUT ROAD, BOULDER
Confronta ELVN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELVN
Enliven Therapeutics Inc
|
20.82 | 1.26B | 0 | -85.21M | -68.53M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-16 | Iniziato | Goldman | Buy |
| 2024-12-13 | Iniziato | BTIG Research | Buy |
| 2024-09-09 | Iniziato | H.C. Wainwright | Buy |
| 2024-06-11 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-09 | Iniziato | Mizuho | Buy |
| 2023-03-29 | Iniziato | Jefferies | Buy |
Mostra tutto
Enliven Therapeutics Inc Borsa (ELVN) Ultime notizie
Enliven Therapeutics (NASDAQ:ELVN) Trading 6.1% HigherHere's Why - MarketBeat
Insider Selling: Enliven Therapeutics (NASDAQ:ELVN) COO Sells 6,667 Shares of Stock - MarketBeat
Volatility clustering patterns for Enliven Therapeutics Inc.Rate Cut & Free Weekly Watchlist of Top Performers - newser.com
What the charts say about Enliven Therapeutics Inc. todayWeekly Stock Recap & Weekly High Return Forecasts - newser.com
Is a relief rally coming for Enliven Therapeutics Inc. holdersWeekly Trade Analysis & High Accuracy Swing Entry Alerts - newser.com
Long term hold vs stop loss in Enliven Therapeutics Inc.2025 Top Decliners & Daily Profit Focused Stock Screening - newser.com
Enliven Therapeutics (NASDAQ:ELVN) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Using Ichimoku Cloud for Enliven Therapeutics Inc. technicals2025 Analyst Calls & Consistent Growth Equity Picks - newser.com
Enliven Therapeutics COO Patel sells $133,992 in stock By Investing.com - Investing.com South Africa
Enliven Therapeutics COO Patel sells $133,992 in stock - Investing.com
Short interest data insights for Enliven Therapeutics Inc.Market Activity Report & Real-Time Volume Spike Alerts - newser.com
What moving averages say about Enliven Therapeutics Inc.Market Activity Report & Low Risk Growth Stock Ideas - newser.com
Why retail investors favor Enliven Therapeutics Inc. stockQuarterly Growth Report & Free Safe Capital Growth Stock Tips - newser.com
Is now a turning point for Enliven Therapeutics Inc.2025 Volatility Report & Smart Money Movement Alerts - newser.com
Enliven Therapeutics stock falls after pricing capital raise of $200M via securities offering - MSN
Developing predictive dashboards with Enliven Therapeutics Inc. dataStop Loss & Weekly Sector Rotation Insights - newser.com
Will Enliven Therapeutics Inc. rebound enough to break evenJuly 2025 Snapshot & Reliable Intraday Trade Alerts - newser.com
Chart based exit strategy for Enliven Therapeutics Inc.Weekly Earnings Recap & Fast Entry Momentum Alerts - newser.com
Top chart patterns to watch in Enliven Therapeutics Inc.July 2025 Retail & Risk Managed Investment Signals - newser.com
Will Enliven Therapeutics Inc. stock recover after recent drop2025 Earnings Impact & Precise Swing Trade Alerts - newser.com
Benjamin Hohl Sells 3,250 Shares of Enliven Therapeutics (NASDAQ:ELVN) Stock - MarketBeat
Enliven Therapeutics (NASDAQ:ELVN) Insider Sells $81,000.00 in Stock - MarketBeat
Enliven Therapeutics CFO sells $22,524 in stock - MSN
Enliven Therapeutics (NASDAQ:ELVN) CEO Samuel Kintz Sells 3,700 Shares - MarketBeat
Enliven Therapeutics Inc Azioni (ELVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Enliven Therapeutics Inc Azioni (ELVN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER |
Sep 29 '25 |
Option Exercise |
2.48 |
3,250 |
8,060 |
26,250 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER |
Sep 29 '25 |
Sale |
20.40 |
3,250 |
66,291 |
23,000 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER |
Sep 26 '25 |
Sale |
20.25 |
4,000 |
81,005 |
927,688 |
| Kintz Samuel | PRESIDENT AND CEO |
Sep 26 '25 |
Sale |
20.06 |
3,700 |
74,228 |
915,392 |
5.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):